Literature DB >> 30359463

Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.

Rima S Zahr1, Jane S Hankins2, Guolian Kang3, Chen Li3, Winfred C Wang2, Jeffrey Lebensburger4, Jeremie H Estepp2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30359463      PMCID： PMC6298812          DOI： 10.1002/ajh.25329

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

1.  Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.

Authors:  Jane S Hankins; Jeremie H Estepp; Jason R Hodges; Martha A Villavicencio; Leslie L Robison; Mitchell J Weiss; Guolian Kang; Jane E Schreiber; Jerlym S Porter; Sue C Kaste; Kay L Saving; Paulette C Bryant; Jeffrey E Deyo; Kerri A Nottage; Allison A King; Amanda M Brandow; Jeffrey D Lebensburger; Oyebimpe Adesina; Stella T Chou; Babette S Zemel; Matthew P Smeltzer; Winfred C Wang; James G Gurney
Journal:  Pediatr Blood Cancer       Date:  2018-05-24       Impact factor: 3.167

2.  Chronic kidney disease and albuminuria in children with sickle cell disease.

Authors:  Marianne McPherson Yee; Shameem F Jabbar; Ifeyinwa Osunkwo; Lisa Clement; Peter A Lane; James R Eckman; Antonio Guasch
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

3.  Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.

Authors:  Jeffrey Lebensburger; Stephen M Johnson; David J Askenazi; Nigel L Rozario; Thomas H Howard; Lee M Hilliard
Journal:  Am J Hematol       Date:  2011-05       Impact factor: 10.047

4.  Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.

Authors:  Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Barry L Shulkin; Jane S Hankins; Russell E Ware
Journal:  Am J Hematol       Date:  2012-12-17       Impact factor: 10.047

Review 5.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272
  5 in total
  5 in total

1.  Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life.

Authors:  Rima S Zahr; Evadnie Rampersaud; Guolian Kang; Mitchell J Weiss; Gang Wu; Robert L Davis; Jane S Hankins; Jeremie H Estepp; Jeffrey Lebensburger
Journal:  Haematologica       Date:  2019-03-19       Impact factor: 9.941

2.  Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.

Authors:  Rima S Zahr; Marianne E Yee; Jack Weaver; Katherine Twombley; Raed Bou Matar; Diego Aviles; Rajasree Sreedharan; Michelle N Rheault; Rossana Malatesta-Muncher; Hillarey Stone; Tarak Srivastava; Gaurav Kapur; Poornima Baddi; Oded Volovelsky; Jonathan Pelletier; Rasheed Gbadegesin; Wacharee Seeherunvong; Hiren P Patel; Larry A Greenbaum
Journal:  Pediatr Nephrol       Date:  2019-04-03       Impact factor: 3.714

Review 3.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

Review 4.  Advances in the diagnosis and treatment of sickle cell disease.

Authors:  A M Brandow; R I Liem
Journal:  J Hematol Oncol       Date:  2022-03-03       Impact factor: 17.388

5.  Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results.

Authors:  Sara R Rashkin; Evadnie Rampersaud; Guolian Kang; Kenneth I Ataga; Jane S Hankins; Winfred Wang; Jeremie H Estepp; Mitchell J Weiss; Jeffrey Lebensburger; Rima S Zahr
Journal:  Br J Haematol       Date:  2021-06-16       Impact factor: 8.615
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.